Item no. |
KR01-A |
Manufacturer |
Cytoskeleton
|
Amount |
2 x 25 ug |
Quantity options |
2 x 25 ug
1 x 1 mg
|
Category |
|
Type |
Proteins |
Specific against |
other |
Purity |
Protein purity is determined by scanning densitometry of Coomassie Blue stained protein on a 12% polyacrylamide gel. All kinesin motor domains are >85% pure. See figure 1 for example purities. |
Citations |
Funk, C. J., Davis, A. S., Hopkins, J. A. and Middleton, K. M. (2004). Development of high-throughput screens for discovery of kinesin adenosine triphosphatase modulators. Anal. Biochem. 329, 68-76. Wada, Y., Hamasaki, T. and Satir, P. (2000). Evidence for a novel affinity mechanism of motor-assisted transport along microtubules. Mol. Biol. Cell 11, 161-169. Endow, S. A. and Waligora, K. W. (1998). Determinants of kinesin motor polarity. Science 281, 1200-1202. |
ECLASS 10.1 |
32160409 |
ECLASS 11.0 |
32160409 |
UNSPSC |
12352202 |
Alias |
Kinesin Motor Domains, Kinesin, microtubule-activated ATPase, kinesin motility, Kinesin heavy chain motor domain protein, kinesin heavy chain |
Similar products |
Kinesin, kinesin heavy chain, Kinesin Motor Domains, microtubule-activated ATPase, kinesin motility, Kinesin heavy chain motor domain protein |
Shipping condition |
Room temperature |
Available |
|
Shipping Temperature |
AT |
Storage Conditions |
On Arrival: 4°C |
Delivery Time |
1-2 Weeks |
Weight (grams) |
9 |
Product Uses |
Measurement of microtubule-activated ATPase activity Identification/characterization of proteins or small molecules that affect motor ATPase activity Identification/characterization of proteins or small molecules that affect kinesin motility Identification/characterization of proteins or small molecules that affect motor/microtubule interactions |
Material |
There are approximately 50 human kinesins that are currently divided into at least 14 classes. Kinesins are involved in almost all aspects of intracellular transport and their well documented role in cell division suggests that they may be excellent targets for anti-mitotic drug discovery. All kinesin proteins contain a conserved motor domain that contains a microtubule binding site and the ATP binding / hydrolysis site. The motor domain of various kinesins have been shown to have widely differing sensitivities to ATP analogs and inhibitory compounds such as monastrol, such results lead the way to the identification of therapeutically useful kinesin specific inhibitors. Cytoskeleton, Inc. has made available a selection of recombinant human kinesin motor domain proteins from 8 of the 14 reported kinesin classes. The proteins are extensively quality controlled for purity (> 85%) and biological activity (microtubule activated ATPase activity must be at least comparable to published data). The protein domains are useful as targets for anti-mitotic drug discovery and as reagents for comparative studies of kinesin class specific motor activities. |
Biological Activity |
Kinesn motor activity is driven by ATP hydrolysis. All motor domain proteins therefore are tested with regards to their microtubule activated ATPase activity. Stringent quality controls that all Cytoskeleton, Inc's purified kinesin motor domains have ATPase activities comparable to published data. |
Figure 1 Legend |
Figure 1. Purity of kinesin motor domain proteins. BimC (BM01), CENP-E (CP01) and Eg5 (EG01) were run on SDS-PAGE gels and stained with coomassie blue. |
Figure 2 Legend |
Figure 2. Microtubule activated kinesin ATPase assay (Cat. # BK060) using kinesin heavy chain motor domain protein (Cat. # KR01) and pre-formed microtubules (Cat. # MT001). Each condition (microtubules (MT) alone, kinesin alone and microtubules + kinesin) was performed in triplicates. |
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.